The drug industry firmly backed ObamaCare, and even ran ads supporting Senators and Congressmen attacked for passing it. The doctor lobby, hospital lobby, and device lobby signed onto the bill, too, albeit with less enthusiasm.
Of course, the bill was loaded up with subsidies that directly benefit health-care providers, and mandates that drive more money to the health sector. The biggest downside for providers: the Independent Payment Advisory Board (IPAB), which could impose cost controls on federal medical spending.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.